Home/Pipeline/RBS for Transcatheter Valve Repair

RBS for Transcatheter Valve Repair

Mitral and Tricuspid Valve Regurgitation

Pre-clinical/ResearchActive

Key Facts

Indication
Mitral and Tricuspid Valve Regurgitation
Phase
Pre-clinical/Research
Status
Active
Company

About Ergosuture

Ergosuture is a private, pre-revenue medical device startup founded in 2019, headquartered in San Francisco. The company has developed a proprietary Roller-Based Suturing (RBS) technology platform, which forms the basis for its Drive'N Roll handheld laparoscopic device and robotic end-effectors, designed to significantly improve suturing efficiency and proficiency. Its pipeline extends beyond general surgery into a novel, suture-based transcatheter valve repair system targeting a large, underserved patient population. Ergosuture's value proposition targets improved surgical outcomes, reduced operative time, and sound hospital economics.

View full company profile

Therapeutic Areas